title: T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
abstract: Type 1 diabetes (T1D) is an autoimmune disease driven by the activation of lymphocytes against pancreatic β-cells. Among β-cell autoantigens, preproinsulin has been ascribed a key role in the T1D process. The successive steps that control the activation of autoreactive lymphocytes have been extensively studied in animal models of T1D, but remains ill defined in man. In man, T lymphocytes, especially CD8(+) T cells, are predominant within insulitis. Developing T-cell assays in diabetes autoimmunity is, thus, a major challenge. It is expected to help defining autoantigens and epitopes that drive the disease process, to pinpoint key functional features of epitope-specific T lymphocytes along the natural history of diabetes and to pave the way towards therapeutic strategies to induce immune tolerance to β-cells. New T-cell technologies will allow defining autoreactive T-cell differentiation programs and characterizing autoimmune responses in comparison with physiologically appropriate immune responses. This may prove instrumental in the discovery of immune correlates of efficacy in clinical trials.
authors.affiliation: INSERM, U986, Hôpital St Vincent de Paul, 82 avenue Denfert Rochereau, 75014 Paris, France.
authors.forename: Roberto
authors.initials: R
authors.lastname: Mallone
authors.forename: Vedran
authors.initials: V
authors.lastname: Brezar
authors.forename: Christian
authors.initials: C
authors.lastname: Boitard
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001323:Autoantibodies / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D015551:Autoimmunity / Q000276:immunology; D002096:C-Peptide / Q000097:blood; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002986:Clinical Trials as Topic; D003921:Diabetes Mellitus, Experimental / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000628:therapy; D018984:Epitopes, T-Lymphocyte / Q000276:immunology*; D005968:Glutamate Decarboxylase / Q000276:immunology; D006681:HLA-D Antigens / Q000378:metabolism; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007328:Insulin / Q000276:immunology*; D050417:Insulin-Secreting Cells / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D051379:Mice; D016688:Mice, Inbred NOD; D008822:Mice, Transgenic; D011498:Protein Precursors / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D002096:C-Peptide; D018984:Epitopes, T-Lymphocyte; D006681:HLA-D Antigens; D007328:Insulin; D011498:Protein Precursors; C013737:preproinsulin; D005968:Glutamate Decarboxylase